Literature DB >> 25346592

Which Psoriasis Patients Develop Psoriatic Arthritis?

Kristine Busse1, Wilson Liao1.   

Abstract

Psoriatic arthritis is a major comorbidity of psoriasis that significantly impairs quality of life and physical function. Because skin lesions classically precede joint symptoms, dermatologists are in a unique position to identify patients at risk for psoriatic arthritis before irreversible joint damage occurs. Here we review the literature to identify the clinical and genetic factors most highly associated with development of psoriatic arthritis, with the goal of assisting dermatologists in risk-stratifying their psoriasis patients.

Entities:  

Keywords:  clinical factors; genetic factors; joint damage; psoriatic arthritis

Year:  2010        PMID: 25346592      PMCID: PMC4206220     

Source DB:  PubMed          Journal:  Psoriasis Forum        ISSN: 1089-3504


  89 in total

1.  Obesity in early adulthood as a risk factor for psoriatic arthritis.

Authors:  Razieh Soltani-Arabshahi; Bob Wong; Bing-Jian Feng; David E Goldgar; Kristina Callis Duffin; Gerald G Krueger
Journal:  Arch Dermatol       Date:  2010-07

2.  Ultrasonographical evaluation of the Achilles' tendon in psoriasis patients.

Authors:  Levent Ozçakar; Alp Cetin; Fatma Inanici; Bayram Kaymak; Cansel Köse Gürer; Fikret Kölemen
Journal:  Int J Dermatol       Date:  2005-11       Impact factor: 2.736

Review 3.  Quality of life in patients with psoriasis: a systematic literature review.

Authors:  John de Korte; Mirjam A Sprangers; Femke M Mombers; Jan D Bos
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

4.  Dactylitis: implications for clinical practice.

Authors:  B M Rothschild; C Pingitore; M Eaton
Journal:  Semin Arthritis Rheum       Date:  1998-08       Impact factor: 5.532

5.  Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients.

Authors:  Hsien-Tzung Liao; Kuan-Chia Lin; Yun-Ting Chang; Chun-Hsiung Chen; Toong-Hua Liang; Wei-Sheng Chen; Kuei-Ying Su; Chang-Youh Tsai; Chung-Tei Chou
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

6.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

7.  Dermatological manifestations in psoriatic arthritis: a follow-up study.

Authors:  V Wright; M C Roberts; A G Hill
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

Review 8.  Psoriasis comorbidities.

Authors:  Lyn Guenther; Wayne Gulliver
Journal:  J Cutan Med Surg       Date:  2009 Sep-Oct       Impact factor: 2.092

9.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

10.  Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.

Authors:  Dafna D Gladman; Philip J Mease; Ernest H S Choy; Christopher T Ritchlin; Renee J Perdok; Eric H Sasso
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

View more
  10 in total

Review 1.  Current concepts and unmet needs in psoriatic arthritis.

Authors:  Farrouq Mahmood; Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2017-11-13       Impact factor: 2.980

2.  Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis.

Authors:  Jürgen Rech; Michael Sticherling; Daniel Stoessel; Mona H C Biermann; Benjamin M Häberle; Maximilian Reinhardt
Journal:  Rheumatol Adv Pract       Date:  2020-07-10

3.  Long-term Outcomes and Prognosis in New-Onset Psoriasis.

Authors:  Axel Svedbom; Lotus Mallbris; Per Larsson; Pernilla Nikamo; Katarina Wolk; Petra Kjellman; Enikö Sonkoly; Liv Eidsmo; Ulla Lindqvist; Mona Ståhle
Journal:  JAMA Dermatol       Date:  2021-04-14       Impact factor: 10.282

Review 4.  IL-36 in chronic inflammation and fibrosis - bridging the gap?

Authors:  Michael Elias; Shuai Zhao; Hongnga T Le; Jie Wang; Markus F Neurath; Clemens Neufert; Claudio Fiocchi; Florian Rieder
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

5.  Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis.

Authors:  Sophie Belman; Jessica A Walsh; Courtney Carroll; Michael Milliken; Benjamin Haaland; Kristina Callis Duffin; Gerald G Krueger; Bing-Jian Feng
Journal:  J Rheumatol       Date:  2021-04-15       Impact factor: 5.346

6.  Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis.

Authors:  Reinhardt Maximilian; Claudia Garbe; Jana Petersen; Matthias Augustin; Natalia Kirsten; Mona H C Biermann; Benjamin M Häberle; Kristina Hagenström
Journal:  Acta Derm Venereol       Date:  2021-10-11       Impact factor: 3.875

Review 7.  IL-36 cytokines in autoimmunity and inflammatory disease.

Authors:  Liping Ding; Xiaohui Wang; Xiaoping Hong; Liwei Lu; Dongzhou Liu
Journal:  Oncotarget       Date:  2017-12-01

Review 8.  Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development.

Authors:  Dawn Queen; Chathumadavi Ediriweera; Liang Liu
Journal:  Front Cell Dev Biol       Date:  2019-12-04

Review 9.  Homocysteine and psoriasis.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

10.  A novel biomarker of MMP-cleaved prolargin is elevated in patients with psoriatic arthritis.

Authors:  Dovile Sinkeviciute; Solveig Skovlund Groen; Shu Sun; Tina Manon-Jensen; Anders Aspberg; Patrik Önnerfjord; Anne-Christine Bay-Jensen; Salome Kristensen; Signe Holm Nielsen
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.